Inovio under pressure as Pfizer vaccine data highlights its lack thereof

Inovio Pharmaceuticals (INO -15.4%) is down, albeit on average volume, pressured by a string of downgrades after it released “positive results” on COVID-19 vaccine candidate INO-4800 that was woefully light on data, a shortcoming that significantly contrasts with the data-heavy announcement from Pfizer and BioNTech on their candidate BNT162b1.

https://seekingalpha.com/news/3587793-inovio-under-pressure-pfizer-vaccine-data-highlights-lack-thereof